These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2989688)

  • 1. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis.
    Hoffman PM; Festoff BW; Giron LT; Hollenbeck LC; Garruto RM; Ruscetti FW
    N Engl J Med; 1985 Aug; 313(5):324-5. PubMed ID: 2989688
    [No Abstract]   [Full Text] [Related]  

  • 2. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS update: HTLV-III/LAV infection.
    Cassens BJ
    Pa Med; 1986 Jan; 89(1):24-6. PubMed ID: 3005945
    [No Abstract]   [Full Text] [Related]  

  • 4. HTLV-III seroconversion in a homosexual patient with common variable immunodeficiency.
    Morell A; Barandun S; Locher G
    N Engl J Med; 1986 Aug; 315(7):456-7. PubMed ID: 3016539
    [No Abstract]   [Full Text] [Related]  

  • 5. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
    Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 7. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
    Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
    N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proof of diaplacental transmission of HTLV III/LAV before the 20th week of pregnancy].
    Schäfer A; Jovaisas E; Stauber M; Löwenthal D; Koch MA
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):88-9. PubMed ID: 3007265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].
    Pokrovskiĭ VV
    Ter Arkh; 1986; 58(10):151-4. PubMed ID: 3541273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro diagnosis and anti-LAV/HTLV III].
    Meyer-Lüerssen D
    J Clin Chem Clin Biochem; 1985 Dec; 23(12):889-90. PubMed ID: 3007653
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue.
    Hauser SL; Aubert C; Burks JS; Kerr C; Lyon-Caen O; de The G; Brahic M
    Nature; 1986 Jul 10-16; 322(6075):176-7. PubMed ID: 3014351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
    Ho DD; Rota TR; Schooley RT; Kaplan JC; Allan JD; Groopman JE; Resnick L; Felsenstein D; Andrews CA; Hirsch MS
    N Engl J Med; 1985 Dec; 313(24):1493-7. PubMed ID: 2999591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiologic screening for antibodies to LAV/HTLV-III in Sri Lanka, 1980-1982.
    Miller RA; Collier AC; Buchanan TM; Handsfield HH
    N Engl J Med; 1985 Nov; 313(21):1352-3. PubMed ID: 2997608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.